Myllia
Myllia perform high-content CRISPR screens in primary human cell models to enable causal, mechanism-resolved drug target discovery. They map the impact of thousands of genetic perturbations at single-cell resolution – a new paradigm to nominate the best possible, genetically validated targets for drug discovery campaigns.
Contact info
- Website:
- https://myllia.com/
WebinarCracking cell dynamics with single-cell proteomics and CRISPR
What can pooled CRISPR screening and protein‑level readouts reveal that transcriptomics alone can’t? Explore how single‑cell genomic perturbations, intracellular protein measurements and surface‑protein profiling expose signalling pathways and clarify antibody specificity.